You are here

Home » Content

MENOPOZUN AĞIZ ETKİLERİ

ORAL EFFECTS OF MENOPAUSE

Journal Name:

  • İstanbul Üniversitesi Diş Hekimliği Fakültesi Dergisi

Publication Year:

  • 2007

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Alterations in the amounts and types of sex hormones during climacterium in women increase the risk of general and oral diseases. Xerostomia in menopause may be one of the reasons for the oral discomforts such as pain, burning sensation, taste alterations as well as a predisposed oral environment for "Burning mouth syndrome", caries and periodontal diseases. Enhanced alveolar bone resorption due to the systemic osteoporosis may cause an accretion in periodontal diseases and tooth loss. Women's oral health is perpetually embodied by biological, psychological and social actions and correlative interactions. Dental professionals must be aware in diagnosing and monitoring conditions to ensure that proper dental treatment is given.
Bookmark/Search this post with
Abstract (Original Language): 
Klimakteryum dönemi boyunca seks hormonlarının miktar ve çeşitlerindeki değişmeler kadınlarda hem genel hem de ağızla ilgili hastalık ortaya çıkması riskini arttırmaktadır. Kserostomi, bu dönemde görülen ağrı, yanma duyusu ve tad duyusu değişmeleri gibi ağız rahatsızlıklarının nedenlerinden biri olabileceği gibi, ağzı "Burning mouth sendromu", diş çürüğü ve dişeti hastalıklılarına yatkın duruma da getirebilmektedir. Bu dönemdeki sistemik osteoporozdan etkilenerek artan alveol kemiği erimeleri önceden var olan periodontal hastalıklarda artışa ve diş kaybına, protez ve implant başarısızlığına neden olabilmektedir. Ancak menopoz, diş tedavileri için, gereken önlemler alındığı sürece bir engel olarak kabul edilmemektedir. Kadınların ağız sağlığı, biyolojik, psikolojik ve sosyal etkiler ve aralarındaki etkileşmeler tarafından devamlı olarak şekillendirilmektedir. Dişhekimleri hastalarına tam bir tedavi sağlayabilmek için bu gibi durumların tanısında ve izlenmesinde daima tetikte olmalıdırlar.
FULL TEXT (PDF): 
PDF icon arastirmax-menopozun-agiz-etkileri.pdf
  • 4
51
57
  • Turkish

REFERENCES

References: 

1. Ben Aryeh H. Gottlieb I. Islı Shalom S, David A, Szargel H. Laufer D. Oral complaints related to menopause. Maturitas. 1996; 24: 185-9
2. Sardella A, Uglietti D, Demarosi F, Lodi G, Bez C. Carrassi A. Benzydamine hydrochloride oral rinses in management of burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 88: 683-6.
3. Grushka M. Clinical features of burning mouth syndrome. Oral Surg Oral Med Oral Pathol. 1987; 63: 30-6.
4. Zakrzcvvska JM. Women as dental patients: Are there any gender differences? Int Dent J. 1996; 46: 548-57.
5. Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev. 2005 Jan 25; (1): CD002779
6. Haneke E. Glossodynia. HNO. 1982; 30: 208¬12.
7. Trikkas G, Nicolatou O, Samara C, Bazopoulou-Kyrkanidou E, Rabavilas AD, Christodoulou GN. Glossodynia: Personality, characteristics and psychopathology. Psychoter Psychosom. 1996; 65: 163-8.
8. Wardrop RW, Hailes J, Burger H, Reade PC. Oral discomfort at menopause. Oral Surg Oral Med Oral Pathol. 1989; 67: 535-40.
.9. Forabosco A, Criscuolo M, Coukos G. Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol. 1992; 73: 570¬4.
10. Maltsman-Tseikhin A, Moricca P, Niv D. Burning mouth syndrome: will better understanding yield better management? Pain Pract. 2007 Jun; 7 (2): 151-62.
11. Ben-Aryeh H, Miron D. Szargel R. Whole saliva secretion rates in oldand young healthy subjects. J Dent Res. 1984; 63: 1147-8.
12. Parvinen T Stimulated salivary flow rate in relation to size and sex. Proc Finn Dent Soc. 1984; 80 (3): 127-30.
13. Laine M. Leimola-Virtanen R. Effect of hormone replacement therapy on salivary flow rate, buffer effect and pH on perimenopausal and postmenopausal women. Arch Oral Biol. 1996 Jan; 41 (1): 91-6.
14. Kullander S, Sonesson B. Studies on saliva in • menstruating, pregnant and postmenopausal
women. Act Endocrinol. 1965; 48: 329-36.
15. Streckfus CF, Baur U, Brown LJ, Bacal C. Metter J. Nick T. Effects of estrogen status and aging on salivary flow rates in healthy Caucasian women. Gerontology. 1998; 44: 32¬9.
16. Mott AE, Grushka M, Sessle BJ. Diagnosis and management of taste disorders and burning mouth syndrome. Dent Clin North Am. 1993; 37: 33-71.
17. Ferris GM. Alteration in female sex hormones: their effect on oral tissues and dental treatment. Compendium. 1993; 14: 1558-64.
18. Steinberg BJ. Women's oral health issues. J Dent Educ. 1999; 63 (3): 271-275.
19. Studen-Pavlovich D, Ranalli DN. Evolution of women's oral health. Dent Clin North Am. 2001; 45 (3): 433-442.
20. Jeffcoat M. The association between osteoporosis and oral bone loss. J Periodontol. 2005 Nov; 76 (11 Suppl): 2125-32.
21. Hildebolt CF. Osteoporosis and oral bone loss. Dentomaxillofac Radiol. 1997 Jan; 26 (1): 3-15.
22. Mavropoulos A, Rizzoli R, Ammann P. Different responsiveness of alveolar and tibial bone to bone loss stimuli.. J Bone Miner Res. 2007 Mar; 22 (3): 403-10.
23. White SC, Rudolph DJ. Alterations of the trabecular pattern of the jaws in patients with osteoporosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Nov; 88 (5): 628-35.
24. Tayeb Y, Goultschin J, Fogel M, Schwartz Z. The relationship between osteoporosis, osteopenia and periodontitis. Refuat Ilapeh Vehashinayim. 2003 Jan; 20 (1): 8-22, 78.
25. Taguchi A, Suei Y, Ohtsuka M, Otani K, Tanimoto K. Hollender LG. Relationship between bone mineral density and tooth loss in elderly Japanese women. Dentomaxillofac Radiol. 1999 Jul; 28 (4): 219-23.
26. Wactawski-Wende J. Periodontal diseases and osteoporosis: association and mechanisms. Ann Periodontol. 2001 Dec; 6(1): 197-208.
27. Wactawski-Wende J, Grossi SG, Trevisan M, Genco RJ, Tezal M, Dunford RG, Ho AW, Hausmann E, Hreshchyshyn MM. The role of osteopenia in oral bone loss and periodontal disease. J Periodontol. 1996 Oct; 67 (10 Suppl): 1076-84.
56
Yıldı/ TÜRKOZAN
28. Tezal M. Wactawski-Wende J. Grossi SG. Ho AW, Dunford R, Genco RJ. The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol. 2000 Sep; 71 (9): 1492-8.
29. Weyant RJ, Pearlstein ME, Churak AP. Forrest K, Famili P, Cauley JA. The association between osteopenia and periodontal attachment loss in older women. J Periodontol. 1999 Sep; 70(9): 982-91.
30. Mattson JS. Cerutis DR. Parrish LC. Osteoporosis: a review and its dental implications. Compend Contin Educ Dent. 2002 Nov: 23 (11): 1001-4, 1006.
31. Von Wowern N. General and oral aspects of osteoporosis: a review. Clin Oral Investig. 2001 Jim; 5 (2): 71-82.
32. Reinhardt RA, Payne JB, Maze CA, Patil KD, Gallagher SJ, Mattson JS. Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women. J Periodontol. 1999; 70: 823-8.
33. Krall EA, Dawson-Hughes B, Papas A. Garcia RI. Tooth loss and skeletal bone density in healthy postmenopausal women. Osteoporos Int. 1994; 4: 104-9.
34. Genco RJ, Grossi SG. Is estrogen deficiency a risk factor for periodontal disease? Compendium. 1998; 19 (supplement 22): 23-29.
35. Klemetti E, Collin HL, Forss H, Markkanen H, • Lassila V. Mineral status of skeleton and
advanced periodontal disease. J Clin Periodontol. 1994; 21: 184-8.
36. Kribbs PJ. Comparison of mandibular bone in normal and osteoporotic women. J Prosthet Dent. 1990; 63: 218-22.
37. Hsieh YD, Devlin H, McCord F. The effect of ovariectomy on the healing tooth socket of the rat. Arch Oral Biol. 1995; 40: 529-31.
38. Von Wowern N, Klausen B, Kollerup G. Osteoporosis: A risk factor in periodontal disease. J Periodontol. 1994; 65: 1134-8.
39. Jeffcoat MK, Chesnut CH HI. Systemic osteoporosis and oral bone loss: evidence shows increased risk factors. JADA. 1993; 124: 49-56.
40. Payne JB, Reinhardt RA, Nummikoski PV, Patil KD. Longitudinal alveolar bone loss in post menopausal osteoporotic/osteopenic women. Osteoporosis Int. 1999; 10: 34-40.
41. Hildebolt CF. Pilgram TK, Dotson M, Yokoyama-Crothers N, Muckerman J, Hauser J,
Cohen S. Kardaris E, Vannier MW. Hanes P, Shrout MK, Civitelli R. Attachment loss with postmenopausal age and smoking. J Periodontal Res. 1997 Oct; 32 (7): 619-25.
42. Hildebolt CF, Pilgram TK. Yokoyama-Crothers N. Vannier MW, Dotson M. Muckerman J, Hauser J, Cohen S, Kardaris EE, Hanes P, Shrout MK, Civitelli R. Alveolar bone height and postcranial bone mineral density: negative effects of cigarette smoking and parity. J Periodontol. 2000 May; 71 (5): 683-9.
43. Payne JB, Reinhardt RA, Nummikoski PV, Dunning DG, Patil KD. The association of cigarette smoking with alveolar bone loss in postmenopausal females J Clin Periodontol. 2000 Sep; 27 (9): 658-64.
44. Pan J. Shirota T, Ohno K, Michi K. Effect of ovariectomy on bone remodeling adjacent to hydroxyapatite-coated implants in the tibia of mature rats. J Oral Maxillofac Surg. 2000 Aug; 58 (8): 877-82.
45. Yamazaki M. Shirota T, Tokugawa Y, Motohashi M, Ohno K, Michi K, Yamagtichi A.Oral Bone reactions to titanium screw implants in ovariectomized animals. Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Apr; 87 (4): 411-8.
46. Duarte PM, Cesar Neto JB, Gonçalves PF, Sallum EA, Nociti FH. Estrogen deficiency affects bone healing around titanium implants: a histometric study in rats. Implant Dent. 2003; 12 (4): 340-6.
47. Sakakura CE, Giro G, Goncalves D, Pereira RM, Orrico SR, Marcantonio E Jr. Radiographic assessment of bone density around integrated titanium implants after ovariectomy in rats. Clin Oral Implants Res. 2006 Apr; 17 (2): 134-8.
48. August M, Chung K, Chang Y, Glowacki J. Influence of estrogen status on endosseous implant integration. J Oral Maxillofac Surg 2001:59: 1285-9.
49. Minsk L, Poison AM. Dental implant outcomes in postmenopausal women undergoing hormone replacement. Compend Contin Educ Dent. 1998; 19: 859-62.
50. Carvalho MD. Benatti BB, Cesar-Neto JB, Nociti FH, da Rocha Nogueira Filho G, Casati MZ, Sallum EA. Effect of cigarette smoke inhalation and estrogen deficiency on bone healing around titanium implants: a histometric
Menopozun Ağız liıkileri
study in rats. J Periodontol. 2006 Apr: 7 (4): 599-605.
51. Nociti FH, Cesar NJ, Carvalho MD, Sallum EA. Bone density around titanium implants may be influenced by intermittent cigarette smoke inhalation: a histometric study in rats. Int J Oral Maxillofac Implants. 2002 May-Jun; 17 (3): 47¬52.
52. Nociti Junior FH, Cesar Neto JB, Carvalho MD, Sallum EA, Sallum AW. Intermittent cigarette smoke inhalation may affect bone volume around titanium implants in rats. J Periodontol. 2002 Sep; 73 (9): 982-7.
53. Daniels TE. Sjogren's syndrome: clinical spectrum and current diagnostic controversies. AdvDent Res. 1996; 10: 3-8.
54. Katusic S. Beard CM, Bergstralh E, Kurland LT. Incidence and clinical features of trigemenal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol. 1990; 27: 89-95.
55. Tsankov N, Vassileva S. Kamarashev J, Kazandjieva J. Kuzeva V. Epidemiology of pemphigus in Sofia, Bulgaria: a 16-year retrospective study (1980-1995). Int J Dermatol 2000; 39: 104-8.
56. Pisantry S. Rafaely B, Pilish UKW. The effect of steroid hormones in the buccal mucosa of menopausal women. Oral Surg Oral Med Oral Pathol. 1975; 40: 346-53.
57. Sooriyamoorthy M, Gower DB. Hormonal influences on gingival tissue: relationship to periodontal disease. J Clin Periodontol. 1989; 16: 201-8.
58. Norderyd OM, Grossi SG, Machtei EE, et al. Periodontal status of women taking postmenopausal estrogen supplementation. J Periodontol. 1993; 64: 957-62.
57
59. Grodstein F, Colditz GA. Stampfer MJ. Postmenopausal hormone use and tooth loss: a prospective study. JADA. 1996; 127:370-7.
60. Paganini-Hill A. The benefits of estrogen replacement therapy on oral health. Arch Intern Med. 1995; 155: 2325-9.
61. Krall EA, Dawson-Hughes B, Hannan MT. Wilson PW, Kiel DP. Postmenopausal estrogen replacement and tooth retention. Am J Med. 1997; 102: 536-42.
62. Jeffcoat MK. Osteoporosis: a possible modifying factor in oral bone loss. Ann Periodontol 1998; 3: 312-21.
63. Payne JB, Zachs NR. Reinhardt RA, Nummikoski PV, Patil K. The association between estrogen status and alveolar bone density changes in postmenopausal women with a history of periodontitis. J Periodontol. 1997; 68: 24-31.
64. Jacobs R. Ghyselen J, Koninckx P, van Steenberghe D. Longterm bone mass evaluation of mandible and lumbar spine in a group of women receiving hormone replacement therapy. Eur J Oral Sci 1996; 104: 10-6.
65. Qi MC, Zhou XQ, Hu J, Du ZJ, Yang JH, Liu M, Li XM. Oestrogen replacement therapy promotes bone healing around dental implants in osteoporotic rats. Int J Oral Maxillofac Surg. 2004 Apr; 33 (3):279-85.
66. Hatch JP, Rugh JD, Sakai S, Saunders MJ. Is use of exogenous estrogen associated with temporomandibular signs and symptoms? J Am Dent Assoc. 2001 Mar; 132 (3): 319-26.
67. LeResche L, Saunders K. Von Korff MR, Barlow W, Dworkin SF. Use of exogenous hormones and risk of temporomandibular disorder pain. Pain 1997; 69: 153-60.

Thank you for copying data from http://www.arastirmax.com